Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 6Rectal Neoplasms 6Colorectal Neoplasms 6Nasopharyngeal Carcinoma 4Nasopharyngeal Neoplasms 3Colonic Neoplasms 3Carcinoma, Squamous Cell 2Pancreatic Neoplasms 1Neoplasms, Squamous Cell 1Neoplasm Metastasis 1Liver Metastases of Colorectal Cancer 1Head and Neck Neoplasms 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Breast Neoplasms 1Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction 1Adenocarcinoma 1

Interventions

Irinotecan 2apatinib 1Paclitaxel 1Oxaliplatin 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction × Fluorouracil × Clear all
NCT03045770 2017-02-07

mFOLFOX Versus mFOLFIRI Versus FOLFPTX as First-line Treatment in AGC or EGJA

Fujian Cancer Hospital

Phase NA Unknown
150 enrolled
Gastrointestinal

Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡